Facial Subunit Composite Tissue Allografts in Nonhuman Primates: I. Technical and Immunosuppressive Requirements for Prolonged Graft Survival
- 1 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 123 (2), 493-501
- https://doi.org/10.1097/prs.0b013e3181954edd
Abstract
Background: Widespread application of composite tissue allotransplantation has been impeded by risks of rejection and conventional immunosuppression. The authors have developed a nonhuman primate composite tissue allotransplantation model that demonstrated reliable and long-term success necessary to progress to preclinical studies. Methods: Composite facial subunits (e.g., skin, muscle, and bone) were transplanted between mismatched cynomolgus monkeys. Vascular supply was based on the common carotid artery and external and internal jugular veins. Facial allografts were heterotopically transplanted to the recipient’s lower abdomen with end-to-side anastomoses of the common carotid artery to the common femoral artery and of both the internal and external jugular veins to the common femoral vein. Animals received tacrolimus monotherapy. Grafts were inspected daily, submitted to biopsy regularly, and studied with magnetic resonance imaging. Results: Thirteen transplants were performed. Two grafts based on the common carotid artery and only the internal jugular vein failed within 3 to 5 days because of venous thrombosis not related to rejection. Subsequent transplants included anastomoses of both the internal and external jugular veins to the common femoral vein without thromboses. Immunosuppression consisted of tacrolimus monotherapy and was tolerated without complications. Long-term success was achieved with rejection-free graft survival (60 to 177 days). Conclusions: The authors have developed the first successful model of facial composite tissue allotransplantation in a nonhuman primate. Technical requirements include preservation of both internal and external jugular venous outflow. Tacrolimus monotherapy permitted prolonged rejection-free graft survival without early complications. This model provides a platform for further investigation of composite tissue allotransplantation tolerance and requirements for indefinite survival.This publication has 25 references indexed in Scilit:
- Clinical Transplantation Tolerance: Many Rivers to CrossThe Journal of Immunology, 2007
- Composite Hemiface/Calvaria Transplantation Model in RatsPlastic and Reconstructive Surgery, 2006
- First human face allograft: early reportThe Lancet, 2006
- Comparative Genetics of MHC Polymorphisms in Different Primate Species: Duplications and DeletionsHuman Immunology, 2006
- Induction of tolerance to composite tissue allograft in a rat modelMicrosurgery, 2006
- A New Composite Facial and Scalp Transplantation Model in RatsPlastic and Reconstructive Surgery, 2003
- New Composite Tissue Allograft Transplantation Model in Mouse with Intravital Microscopic Evaluation of MicrocirculationJournal of Reconstructive Microsurgery, 2003
- Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockadeTransplantation, 2003
- Split tolerance to a composite tissue allograft in a swine modelTransplantation, 2003
- Conserved MHC Class I Peptide Binding Motif Between Humans and Rhesus MacaquesThe Journal of Immunology, 2000